Scientists in the US are testing a drug called Ibudilast, which is used to treat asthma and strokes in Japan and Korea, as a “cure” for meth addiction. Researchers believe the drug may block methamphetamine cravings in the brain. If FDA testing proves to be successful the drug “could be approved by 2018.” One researcher from UCLA says preliminary testing indicates that “Ibudilast may dampen craving and improve cognitive functioning.” Currently the only treatment available for meth addiction in the US consists of rehab and counseling.
Read the full article here.